Skip to content

プレスリリース

Illumina to Present at J.P. Morgan Healthcare Conference

SAN DIEGO, Jan 04, 2011 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the J.P. Morgan Healthcare Conference in San Francisco, California, on January 11, 2011. The live webcast is scheduled to begin at 4 p.m. PT and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer.

The live webcast can be accessed under the "Corporate/Investor Information" tab of Illumina's web site at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

SOURCE: Illumina, Inc.

Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Sr. Manager, Public Relations
858-882-6822
wgrabill@illumina.com

Recent Articles

Project Baby Bear – California Pilots Public Health Coverage for WGS
Project Baby Bear – California Pilots Public Health Coverage for WGS
Knowledge is Power: Unlocking the Potential of the Genome
Knowledge is Power: Unlocking the Potential of the Genome
Illumina Accelerator Invests in Four Startups for Ninth Cycle
Illumina Accelerator Invests in Four Startups for Ninth Cycle